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Abstract: Microalgae are important biological 
resources that have a wide range of biotechnological 
applications. Due to their high nutritional value, 
microalgae such as Spirulina and Chlorella are being 
mass cultured for health food. A variety of high-value 
products including polyunsaturated fatty acids (PUFA), 
pigments such as carotenoids and phycobiliproteins, and 
bioactive compounds are useful as nutraceuticals and 
pharmaceuticals, as well as for industrial applications. In 
terms of environmental biotechnology, microalgae are 
useful for bioremediation of agro-industrial wastewater, 
and as a biological tool for assessment and monitoring of 
environmental toxicants such as heavy metals, pesticides 
and pharmaceuticals. In recent years, microalgae have 
attracted much interest due to their potential use as 
feedstock for biodiesel production. In Malaysia, there 
has been active research on microalgal biotechnology 
for the past 30 years, tapping into the potential of our 
rich microalgal resources for high-value products and 
applications in wastewater treatment and assessment 
of environmental toxicants. A culture collection of 
microalgae has been established, and this serves as 
an important resource for microalgal biotechnology 
research. Microalgal biotechnology should continue to 
be regarded as a priority area of research in this country. 
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Introduction
Algae are lower plants without structures such as 
leaves, roots and stems. In modern classification schemes 
based on molecular phylogenetic systematics, algae are 
not classified under the Kingdom Plantae although they 
resemble very much of higher plants1. The eukaryotic 
algae are grouped under the Kingdom Protista while the 
prokaryotic algae cyanobacteria or blue-green algae are 
classified as bacteria (Kingdom Monera). Algae include 
the microscopic (microalgae) and macroscopic forms 
(macroalgae), the latter consist of mainly seaweeds. 
In terms of the diversity in size, algae range from 
picoplankton of only 0.2 – 2.0 mm in diameter to giant 
kelps with fronds up to 60 m in length2. The number 
of species of algae has been estimated to be one to ten 
million, most of which are microalgae. Cyanobacteria 
are distinguished from other bacteria as they carry out 
oxygenic photosynthesis. Cyanobacteria were the first 
colonizers of Earth, and through photosynthesis, they 
released oxygen which enabled other life forms to live 
on this planet. The algae are further divided into several 
major groups, namely green, brown and red algae based 
on their pigmentation. 
While algae are widely found in aquatic habitats, 
they also inhabit terrestrial habitats, including extreme 
environments such as snow and glaciers in the Arctic 
and Antarctic.3,4 Algae are also present in the air as 
they may be dislodged from the soil and splashed up by 
the rain.5 There have been very few studies on airborne 
algae although they can exert unfavorable impact on 
human health. Some airborne algae have been shown 
to produce allergic reactions in humans. A recent study 
conducted at Bukit Jalil, Kuala Lumpur found that 
cyanobacteria were the major airborne algae, with the 
dominance of Phormidium tenue.6
Algae represent an important group of organisms for 
biotechnological exploitation, especially for valuable 
products, processes and services, with important 
impact in food and pharmaceutical industries as well 
as in public health. A diverse range of metabolites with 
various bioactivities are produced in algae that are yet 
to be fully exploited.7 Microalgae such as Spirulina and 
Chlorella have been consumed as food supplements 
(nutraceutical) by humans and also used as animal 
feeds. In addition, microalgae have been exploited for 
wastewater treatment and used as a biological tool for 
assessment of environmental toxicants. Malaysia is 
endowed with rich microalgal resources that are yet 
to be fully exploited for biotechnological applications. 
The aim of this paper is to give an overview of the various S 25
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biotechnological applications of microalgae, as well as 
to trace the developments of microalgal biotechnology 
research in Malaysia.
Microalgae as food and dietary supplements
Some of the microalgae have been consumed as food 
or health food due to their high nutritional value. For 
instance, Spirulina has been harvested for food by the 
natives in Mexico and Chad (Africa) since ancient 
times.2 In Mexico, Spirulina is collected from Lake 
Texcoco and used for making dry cake called tecuitlatl. 
In Chad, Spirulina is harvested from the alkaline lake 
Kossorom for the preparation of dry cake known as ‘dihe’. 
In the present day, Spirulina still contributes significantly 
to the economy of Chad as the local trading value of 
‘dihe’ is worth more than US$ 100,000.8 
Presently,  Spirulina is being cultured on a large 
scale using open ponds for commercial production of 
the biomass as dietary supplement in countries such 
as Thailand, China, United States and India. It is 
estimated that the annual worldwide production of 
Spirulina ranges from 3000 to 4000 metric tons.9 Spriulina 
is regarded as a nutritious food due to its high content 
of proteins, g-linolenic acid, vitamins and minerals. 
In addition to being consumed as a food product, 
Spirulina is known to have therapeutic implications, 
including for health problems such as diabetes, arthritis, 
anaemia, cardiovascular diseases and cancer.10 Spirulina is 
also useful as a functional ingredient as it is incorporated 
into various food products to enhance their nutritional 
qualities and for therapeutic management of chronic 
disorders such as diabetes, hypertension and heart 
disease.11 Spirulina is also well-known for its antioxidant 
compounds such as phycocyanin and vitamin E.12,13
Another cyanobacterium that has been consumed as 
food since 2,000 years ago by the Chinese is Nostoc.14 
The alga is regarded as a healthy food due to its high 
protein and pigment contents, as well as low fat content. 
The main species of Nostoc with economic value is 
Nostoc flagelliforme or known as “fa cai” by the Chinese. 
Nostoc flagelliforme contains high amounts of pigments 
such as echinenone and myxoxanthophyll, as well as 
allophycocyanin, phycocyanin and chlorophyll.15 It also 
contains 19 amino acids, of which eight are essential to 
human nutrition, making up 35.8-38.0% of the total 
amino acids.14 The alga has also been used in traditional 
Chinese medicine since 400 years ago, for the treatment 
of diarrhea, hypertension and hepatitis. Another species, 
Nostoc sphaeroides or locally known as Ge-Xian-Mi is 
collected from paddy fields in certain regions of China, 
and used as food and herbal ingredients.2 
Chlorella is another microalga that has been mass 
cultured for commercial production of health food in the 
form of pills and powder. The first pilot plant for mass 
culture of Chlorella was tested in Boston, USA, and this 
was followed by other cultivation plants in Israel, Japan 
and Czechoslavakia.16 The first commercial production 
plant of Chlorella was established in Japan in 1961 by 
Nihon Chlorella Inc. Following this, Chlorella factories 
were constructed in countries such as Taiwan, Malaysia 
and Indonesia. By 1980, some 46 large-scale plants 
were established in Asia producing more than 1000 kg 
of Chlorella biomass per month.17 There are more than 
70 companies producing Chlorella in Taiwan, and the 
world annual sales of Chlorella are more than US$ 38 
billion. However, the plant in Malaysia was discontinued 
in the early 70’s. Presently, Chlorella products marketed 
in Malaysia are mainly imported from Japan and Taiwan. 
The nutritional value of Chlorella is due to their 
high contents of proteins (51-58% dry weight) 
and carotenoids, with a wide range of vitamins.18 
In addition, the alga contains b-glucan, which is an 
active immunostimulator, and has other beneficial effects 
in scavenging free radicals and reducing blood lipids.16 
An additional product termed ‘Chlorella Growth Factor’ 
has been distributed as an agent to improve the growth 
of lactic bacteria. 
High-value products from microalgae
Microalgae are a potential source of a wide range of S 26
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high-value products for biotechnological exploitation, 
which include polyunsaturated fatty acids (PUFA), 
carotenoids, phycobiliproteins, polysaccharides and 
phycotoxins (Table 1). A multitude of compounds 
are produced by microalgae as defense against stress 
conditions. An advantage of exploiting microalgae for 
bioactive molecules is that they can be cultured on a 
large scale for production of the desired chemicals. 
The advent of molecular biology has led to a better 
understanding of the biosynthesis and physiological 
functions of the bioactive molecules in microalgae. 
Genomic projects have been embarked on microalgae 
such as Alexandrium, Chlamydomonas, Nostoc and 
Synechococcus.19 Efforts have also been invested to 
develop transgenic microalgae as ‘green cell factories’ 
to produce new pharmaceuticals using genetic 
transformation techniques.20
Table 1: Biotechnological applications of products from microalgae.
Product Applications Microalgal Producers
Polyunsaturated fatty acids (PUFA)
Eicosapentaenoic acid (EPA)  Nutritional supplements, aquaculture feed Pavlova, Nannochloropsis, 
Monodus & Phaeodactylum
Docohexaenoic acid (DHA) Infant formula, nutritional supplements, 
aquaculture feed
Crypthecodiuimu & 
Schizochytrium
g-linolenic acid (GLA) Nutritional supplements Spirulina
Arachidonic acid (AA) Nutritional supplements Porphyridium
Phycobiliproteins
Phycocyanin Natural dye for health food and cosmetics 
(lipsticks and eyeliners) antioxidant
Spirulina platensis
Phycoerythrin Fluorescent agent, tool for biomedical research, 
diagnostic tool
Red algae 
(e.g. Porphyridium cruentum)
Carotenoids
b-carotene Food colourant; antioxidant; 
cancer-preventive properties
Dunaliella salina
Astaxanthin Pigmenter for salmon, antioxidant Haematococcus pluvialis
Mycosporine-like amino acids (MAA) UV-screening agent ; sunscreen Aphanizomenon flos-aquae
Polysaccharides Viscosifiers, lubricants and flocculants for 
industrial applications; antiviral agent
Porphyridium cruentum
Phycotoxins 
– okadaic acid, gonyautoxins, 
& yessotoxins
Experimental tools for investigations on 
neurodegenerative diseases
Dinoflagellates 
(e.g. Amphidinium, 
Prorocentrum & Dinophysis)
Lipids – triglycerides and 
hydrocarbons
Biofuels Chlorella protothecoides 
Botryococcus brauniiS 27
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Polyunsaturated Fatty Acids (PUFA)
Some of the marine microalgae are a potential 
source of long chain polyunsaturated fatty acids 
(LC-PUFA), especially eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA), which have been 
implicated to be beneficial in the prevention of 
cardiovascular disease. The conventional source of such 
LC-PUFA is fish oil; however, fish do not synthesize 
these fatty acids but acquire them through their diet, 
which consists of marine microalgae. Microalgae-
derived DHA is already commercially available in the 
market. A study showed that consumption of DHA-rich 
algal oil to be equivalent to cooked salmon in providing 
DHA to plasma and red blood cells in 32 healthy men 
and women.21 
In humans, DHA is important for the proper 
development of brain and eye in infants and has been 
shown to support cardiovascular health in adults.22,23 
One of the major producers of DHA from algae is Martek 
Biosciences Corporation in USA. The oil extracted from 
Crypthecodinium cohnii contains 40-50% DHA but no 
EPA or other LC-PUFA.24 The main application of the 
DHA oil is as a supplement in infant formula. Another 
company, OmegaTech (USA) cultures Schizochytrium 
to produce algal oil known as DHA Gold for use as an 
adult dietary supplement in food and beverages as well 
as animal feeds. Other applications include food for 
pregnant and nursing women and for cardiovascular 
health.23 
Carotenoids
Carotenoids in algae mainly serve as accessory pigments 
in photosynthesis, and they are derived from 5-carbon 
isoprene units that are polymerised enzymatically 
to form highly-conjugated 40-carbon structures.7 
The compounds which consist of only hydrocarbons 
are carotenes while those with oxo, hydroxyl or expoxy 
groups are called xanthophylls. Of the 400 known 
carotenoids, the main types that have been used 
commercially include b-carotene and astaxanthin, and 
to a lesser extent, lutein, zeaxanthin and lycopene.17 
Carotenoids are used as natural food colorants and 
additive for animal feeds, as well as in cosmetics. 
In terms of nutritional relevance, certain carotenoids, 
especially b-carotene act as provitamin A. Carotenoids 
are also known to have therapeutic value, including 
anti-inflammatory and anti-cancer activities, which are 
largely attributed to their antioxidant properties.12 
Amongst microalgae, the green alga Dunaliella salina 
has been mass cultured using open ponds for the 
production of b-carotene. The alga grows in water with 
high salt content and is able to produce b-carotene up 
to 14% of its dry weight.25 Industrial plants growing this 
microalga have been set up in Australia, Israel, USA 
and China.26,27 ß-carotene from Dunaliella has higher 
antioxidant activity than synthetic b-carotene as the 
latter consists of all- trans-isomer while the algal product 
has both cis- and trans-isomers.28 The algal products 
in the market are in the form of b-carotene extracts, 
Dunaliella powder for human use and dried Dunaliella for 
feed use. Administration of algal b-carotene to mouse 
and humans has been shown that it has protective effect 
against atherosclerosis. For instance, administration 
of  Dunaliella rich in b-carotene inhibits low density 
lipoprotein (LDL) oxidation and influences plasma 
triglycerides, cholesterol and high density lipoprotein 
(HDL) levels in mouse and humans.29 Supplementation 
of b-carotene from Dunaliella bardawil has been shown 
to inhibit oxidation of LDL from diabetic patients, 
and may be important in delaying the development of 
atherosclerosis.3 Besides b-carotene, other carotenoids 
from  Dunaliella such as phytoene and phytofluene 
are also known to have health benefits, especially in 
protection against UV and oxidative damage leading to 
premature ageing and other disorders.31 
Another carotenoid from microalgae that has 
commercial applications is astaxanthin. The pigment 
is a keto-carotenoid produced mainly by the green alga 
Haematococcus pluvialis. When under unfavourable 
growth conditions, the alga changes from thin-wall 
flagellated stage to red thick-wall resting stage due to S 28
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the accumulation of astaxanthin, which can reach 
up to 4-5% dry weight.32 Astaxanthin is mainly used 
a food-colouring agent, natural feed additive for the 
poultry industry and for aquaculture, especially as 
a feed supplement for salmon, trout and shrimp.33 
The annual worldwide aquaculture market of this 
carotenoid is worth US$200 million with an average 
price of US$2,500/kg .34
Recently, astaxanthin has also been sold as a 
nutraceutical for humans in the form of encapsulated 
product. In addition, astxanthin-rich Haematococcus 
has been marketed as a dietary supplement for human 
consumption.33 The health benefit of this product is 
mainly due to its strong antioxidant activity, which is 
100 times more than a-tocopherol.35 Studies have 
shown that astaxanthin has protective effects against 
diseases such as cancers, inflammatory diseases, 
metabolic syndrome, diabetes, diabetic nephropathy, 
neurodegenerative diseases and eye diseases.36 
The protective effects are likely to be mediated through 
its prevention against oxidative damage and cellular 
necrosis or apoptosis induced by oxidative stress. For 
instance, it has been shown that administration of 
astaxanthin in alloxan-induced diabetic rats can partially 
reverse oxidative stress in neutrophils.37 In addition, 
feeding of astaxanthin to rats has been shown to have a 
protective effect against ethanol-induced gastric ulcer.38 
Phycobiliproteins
Phycobiliproteins are water-soluble accessory 
photosynthetic pigments found in algae such as 
cyanobacteria, rhodophytes (red algae), cryptophytes 
and glaucophytes. There are three major types of 
phycobiliproteins, namely phycocyanin, allophycocyanin 
and phycoerythrin, which differ in their spectral 
properties. The contents of phycobiliproteins in 
microalgae vary with environmental conditions, 
especially intensity and spectral quality of light. For 
instance, phycocyanin contents in Spirulina platensis 
may vary from 0.11 to 12.7% dry weight when cultured 
at different light intensities.39 
Two microalgae that have been exploited for 
commercial production of phycobiliproteins are 
Spirulina and Porphyridium. The major applications of 
the pigments are as natural dyes for food and cosmetic 
products as well as fluorescent markers in biomedical 
research diagnostic tools.40 For instance, phycocyanin is 
marketed as a product called Lina Blue by Dainippon 
Ink and Chemicals (Sakura) for use in chewing gum, 
ice sherberts, popsicles, candies, soft drinks, dairy 
products and wasabi.17 Another form of this pigment is 
used in natural cosmetics such as lipstick and eyeliners. 
As fluorescent markers, phycobiliproteins are widely 
used in immunology laboratories, as they can serve as 
labels for antibodies, receptors and other biological 
molecules in fluorescence-activated cell sorter, as 
well as in fluorescence microscopy. The prices of 
phycobiliprotens may range from US$ 3 to US$ 1500/
mg for certain cross-linked pigments.17 
Recent studies have shown that phycocyanin has 
health-promoting properties and a broad range of 
potential pharmaceutical applications. The beneficial 
effects of the pigment are mainly due to its antioxidant 
activities. The antioxidant potential of phycocyanin 
has been shown to be 16-times more efficient than 
trolox (vitamin E analog) and 20 times more effective 
than vitamin C based on its protective effect on human 
erythrocytes against lysis induced by peroxyl radicals.41 
The pigment has also been shown to have protective 
effects in human pancreatic cells42 and against arthritis in 
rats43 by attenuating oxidative stress. Administration of 
selenium-enriched phycocyanin from Spirulina platensis 
has been shown to protect against the development of 
atherosclerosis in hamster through its inhibitory effect 
on pro-oxidant factors.44 
Bioactive compounds
As microalgae possess a multitude of physiological, 
biochemical and molecular strategies to cope with stress, 
they are capable of synthesising a variety of bioactive 
chemicals. The bioactive compounds are usually   
secondary metabolites, which include various types of S 29
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substances  ranging from organic acids, carbohydrates, 
amino acids and peptides, vitamins, growth substances, 
antibiotics, enzymes to toxic compounds. The 
metabolites show a wide range of biological activities, 
including anticancer, antiviral, antioxidant and 
immunomodulatory effects. There is potential of 
discovering new drug leads from such metabolites. 
Of the various groups of microalgae, the cyanobacteria 
seem to feature most prominently as sources of bioactive 
compounds.19 
Toxic metabolites from microalgae (phycotoxins) 
are a promising group of bioactive molecules for 
biotechnological exploitation. Such compounds are 
produced mainly by dinoflagellates and cyanobacteria, 
especially those that cause harmful algae blooms in 
either marine or freshwater environments. Excessive 
growth of dinoflagellates may cause discolouration of 
the sea, forming red tides while blooms of cyanobacteria 
in lakes due to excessive nutrients, especially nitrogen 
and phosphorus may cause eutrophication. While about 
300 species of microalgae have been reported to form 
algae blooms, nearly one fourth of these species are 
known to produce toxins.45 The toxins can cause 
health hazard to humans, domestic animals and wildlife 
with toxicological effects including neurotoxicity, 
hepatoxicity, cytotoxicity and dermatoxicity.46 The most 
common freshwater algal toxins include microcystins, 
homo- and anatoxin-a and saxitoxins, which are 
produced by cyanobacteria such as Microcystis, Anabaena, 
Oscillatoria and Nostoc species. Human poisoning due 
to toxins of marine dinoflagellates include paralytic 
shellfish poisoning, diarrheic shellfish poisoning, 
neurotoxic shellfish poisoning, and ciguatera fish 
poisoning.47 The common dinoflagellates that produce 
such toxins include Alexandrium,  Dinophysis,  Karenia 
and Gymnodinium species. 
Phycotoxins show a wide range of biological activities 
including cytotoxic, antitumor, antibiotic, antifungal, 
immunosuppressant and neurotoxic activities, which 
offer a great potential for biotechnological exploitation.47 
Many patents relating to such toxins have been filed. 
As many of the algal toxins are neurotoxic compounds, 
they are suitable as experimental tools used to explore 
how the brain works and for investigations on 
neurodegenerative diseases. For instance, okadaic acid 
from Dinophysis is a potent neurotoxin used in the studies 
on the therapeutic effects of atypical antipsychotic 
drugs in the treatment of cognitive impairment 
and schizophrenia.48 In addition, pectentoxins from 
Dinophysis show cytotoxic activity against several human 
cancer cell lines.49 The macrolide amphidinolides 
produced by Amphidinium has been shown to have potent 
antitumour properties against murine lymphoma L1210 
and human epidermoid carcinoma KB cells.50 The major 
challenge faced in the biotechnological exploitation of 
dinoflagellate toxins is the need to produce sufficient 
quantities of the bioactive materials. The main problem 
faced in culturing dinoflagellates is their lower growth 
rates compared to other typical microalgae.47 
Amongst the toxins from cyanobacteria, those isolated 
from  Lyngbya majuscula show a variety of chemical 
structures, including nitrogen-containing compounds 
and polyketides.51 One of the compounds, curacin A is a 
potent inhibitor of cell growth and mitosis that inhibits 
microtubulin assembly. It has been shown to have 
cytotoxic activity against L1210 leukaemic cell line 
by inhibiting tubulin polymerisation.52 A neurotoxic 
lipopeptide, kalkitoxin isolated from the microalga 
is a sodium channel block, which is a useful tool to 
understand neural transmission.53 Successful chemical 
synthesis of this toxin and its analogues, and testing 
of their biological activities was recently reported by 
Umezawa et al. (2012).54
Several cyclic or linear peptides and depsipeptides 
isolated from cyanobacteria are protease inhibitors, 
which have potential applications in medicine for 
treatment of diseases such as strokes, coronary artery 
occlusions and pulmonary emphysema.19,51 For instance, 
aeruginosins isolated from Microcystis aeruginosa 
have been shown to have inhibitory activity against 
thrombin, plasmin and trypsin.55 Other depsipeptides 
such as micropeptin, microcystilide, cyanopeptolin, 
oscillapeptin and nostocyclin are inhibitors of enzymes S 30
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such as trypsin, plasmin, thrombin and chymotrypsin.56 
Microalgae are also potential sources of antiviral 
compounds that are yet to be fully explored. For instance, 
screening of extracts from 600 cultures of cyanobacteria 
showed a hit rate of 10% in inhibiting cellular infection 
of HIV-1, HSV-2, and antirespiratory syncytia virus.57 
A novel compound from cyanobacteria, cyanovirin-N 
has been shown to be a potent virucidal agent against HIV, 
which blocks the interaction of the viral glycoprotein 
gp120 with CD4.58 There is potential of developing a 
topical vaginal microbicide against HIV based on this 
compound.59 The sulfated polysaccharide calcium 
spirulan derived from Spirulina platensis shows antiviral 
activity by inhibiting the entry of enveloped viruses 
such as Herpes simplex, human cytomegaloviruses and 
measles virus into the cell.60,61 Sulfated polysaccharide 
from the red alga Porphyridium has also been shown to 
display antiviral activities against HSV-1, HSV-2 and 
Varicella zoster virus by preventing the adsorption of 
the virions.62 
Bioactive molecules with anticancer activities 
are one major group of targeted compounds from 
microalgae. A large-scale screening of about 1,000 
extracts of cyanobacteria isolated from various habitats 
for antineoplastic activity was conducted by Patterson 
et al. (1991).63 Antineoplastic activity was assessed 
based on the inhibitory effects on the differentiation of 
human leukaemic cells, and a hit rate of about 7% was 
reported. In another screening, more than 501 extracts 
from marine microalgae were assessed using mechanism-
based assays, including activities against protein kinase 
C, protein tyrosine kinase and inosine monophosphate 
dehydrogenase.64 A novel chlorosulfolipid isolated from 
Poteriochromonas malhamensis was shown to inhibit 
protein tyrosine kinase activity. Marine cyanobacteria 
are potential producers of bioactive compounds that are 
effective in killing cancer cells by inducing apoptotic 
death, or affecting cell signaling through activation of 
signaling enzymes belonging to protein kinase C family.65
The polyketide-derived macrolides scytophycins 
isolated from Scytonema pseudohofmanni have been 
shown to inhibit a variety of mammalian cells, 
including the epidermoid carcinoma cells.66 The 
compounds are also active against intraperitoneally 
implanted lymphocytic leukaemia and lung carcinoma.67 
Another metabolite isolated from Nostoc ATCC 53789, 
cryptophycin is a prominent anticancer compound68 
while scytonemin isolated from Stigonema is a 
protein serine/threonine kinase inhibitor, which may 
provide an excellent drug with antiproliferative and 
antiinflammatory activities.69 
Use of microalgae for biodiesel production
The potential use of microalgae as feedstock for 
biodiesel production has been receiving increased 
interest in recent years. It is advantageous to use 
microalgae for biodiesel production compared to other 
crop plants because it will not compromise production 
of food, fodder and other feedstocks derived from 
those crops. In Malaysia, palm oil has been the major 
raw material for biodiesel production; however, the 
supply of palm oil is not sufficient to meet the demand. 
There is concern that there may not be enough palm 
oil left for food production if it is used for biodiesel 
production. Microalgae appear to be the only source 
of biodiesel that has great potential to replace fossil 
diesel.70 The oil content of microalgae may range from 
16 to 68% dry weight.71 The oil yield from microalgae 
can reach up to 136,900 L/ha compared to other plant 
crops, which range from 172 to 5950 L/ha. Manipulation 
of culture conditions can further enhance the lipid 
content of microalgae. For instance, some microalgae 
can accumulate storage lipids (triglycerides) up to 
70% dry weight under nitrogen-starvation.72 Amongst 
the microalgae, Chlorella appears to be a potential 
feedstock for biodiesel production. For instance, 
Chlorella protothecoides produces a crude lipid content 
of 55.2% dry weight when grown under heterotrophic 
condition on glucose.73 The biodiesel produced by 
this alga has been shown to be of high quality, with 
high heating value and viscosity. S 31
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Mass culture of microalgae not only generates biomass 
for biodiesel production, it is also useful for mitigating 
the problem of global warming due to carbon dioxide 
(CO2). Microalgae have much higher photosynthetic 
efficiency than terrestrial plants, and are able to grow at 
high CO2 level and temperature.74 In theory, microalgae 
are able to use up 9% of the incoming solar energy 
to produce 280 tons of dry biomass per ha-1 yr-1 while 
sequestering about 513 tons of CO2.75 Species which 
have been shown to grow at high levels of CO2 include 
Spirulina sp., Scenedesmus obliquus and Chlorella vulgaris 
which can grow up to 18% CO2.76 Such microalgae 
are useful for bioremediation of flue gas which 
contains 10 – 13% CO2.77 The CO2 fixation rate by 
Chlorella vulgaris grown in flue gas can reach 4.4 g 
CO2 L-1 day-1. With a gas residence time of 2 s, 
Chlorella vulgaris can remove up to 74% of the CO2 when 
grown in a photobioreactor.78 Thus, an integrated system 
of using microalgae for CO2 biofixation and biodiesel 
production will be most attractive.
Applications of microalgae in environmental 
biotechnology
Microalgae have many applications in environmental 
biotechnology, especially for bioremediation, bioassay 
and biomonitoring of environmental toxicants. The 
discharge of wastewater containing various contaminants 
into the aquatic ecosystems is a major concern as it can 
be a threat to public health. The high rate algae pond 
(HRAP) system has been shown to be an efficient system 
to treat wastewater.79,80 The system consists of shallow 
pond mixed by paddle-wheels to enhance nutrient 
transfer and photosynthetic efficiency to optimise algal 
growth. The HRAP system is particularly suitable for 
tropical climate with the warm weather and abundance 
of sun light throughout the year. Apart from the efficient 
reduction of pollutants such as chemical oxygen demand 
(COD), biological oxygen demand (BOD), nitrogen 
and phosphorus, HRAP generates algal biomass that 
has potential applications as animal feed and feedstock 
for biodiesel. Microalgae grown in HRAP have been 
shown to be useful in treating various wastewaters 
including rubber effluent, palm oil mill effluent (POME) 
and municipal wastewater.80,81 Reduction of phosphate 
from anaerobically digested starch factory wastewater of 
more than 99% was attained by Spirulina platensis grown 
in HRAP.82 The HRAP system is useful for tertiary 
treatment of the wastewater after undergoing the 
conventional treatment before discharge.79 For instance, 
Chlorella vulgaris grown in HRAP has been shown to 
be useful for final polishing of textile wastewater before 
discharge, especially for colour removal.83 Besides single-
species culture, a combination of several microalgae 
has also been evaluated in some studies for efficiency 
in wastewater treatment. For instance, a consortium of 
five microalgae grown in HRAP was successfully used to 
treat landfill leachate.84 
In addition to suspended cultures, immobilised 
microalgae system can further enhance the efficiency in 
the removal of environmental toxicants.85 For instance, 
Chlorella vulgaris immobilised in alginate was found 
to be effective in removing colour from textile dyes.86 
Immobilised Chlorella vulgaris and Scenedesmus obliquus 
have been shown to be effective in removing nitrogen and 
phosphorus from urban wastewater operated on a semi-
continuous mode.87 In another study, co-immobilisation 
of microalgae and bacteria have been shown to be 
more effective in removing nutrients such as nitrate, 
ammonium and phosphate from wastewater compared 
with immobilised microalgae without bacteria.88 
While microalgae that are tolerant to toxicants are 
useful in bioremediation, sensitive species are useful 
tools for bioassay and biomonitoring of environmental 
pollutants.89 Microalgae have been used as bioassay 
organisms to assess the toxicity of pollutants such as 
heavy metals, pesticides and pharmaceuticals. Heavy 
metals have been detected in the aquatic ecosystems and 
even in marine organisms such as fish and mussel.89,90 
Residual organochlorine and organophosphate 
pesticides have been detected in the Selangor River 
due to intense agricultural and urban activity.91 
The presence of pharmaceutically-active compounds 
such as antibiotics in the environment, due to their 
excess use in aquaculture and animal husbandry has also S 32
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been a concern in recent years.92 
While chemical assays are used to determine the 
contents of the pollutants, only bioassays can really 
assess the biological effects on living organisms. Adverse 
impacts of environmental toxicants on microalgae can 
be far-reaching as they form the basis of the food chain. 
Thus, microalgae are often included in the bioassays 
of environmental pollutants. The common microalgae 
used for bioassays of toxicants include Pseudokirchneriella 
subcapitata,  Dunaiella tertiolecta,  Isochrysis galbana, 
Chlorela spp.89,93 Various endpoints are used to assess 
the toxicity of pollutants to microalgae and these are 
usually based on the effects on growth, photosynthesis, 
movement behavior, oxidative stress markers, 
biochemical composition and pigmentation.89,94
Runoff of excess nutrients from fertilizers and industrial 
wastewater to the aquatic environment can trigger 
overgrowth of microalgae that causes eutrophication.95 
Microalgae are useful tools for the assessment of 
nutrient enrichment due to nitrogen and phosphorus. 
For instance, three tropical microalgae, namely 
Chlorella vulgaris,  Scenedesmus quadricauda and 
Ankistrodemsus convolutus were found to be useful for 
the assessment of nitrogen and phosphorus enrichment 
in freshwater ecosystems.96 
Development of microalgal biotechnology in Malaysia
In Malaysia, early studies on microalgae focused 
mainly on the taxonomy and ecological distribution of 
freshwater algae. The fundamental studies in phycology 
have resulted in the publications of several checklists 
and monographs that documented the diversity of 
microalgae in Malaysia.97-99 The early studies in applied 
phycology focused mainly on the use of microalgae for 
the treatment of agro-industrial wastewater.100 Efficient 
removal of nitrogen from palm oil mill effluent (POME) 
was attained using such a system. Following this, the 
HRAP system was shown to be useful for the treatment 
of agro-industrial wastewaters such as rubber effluent80, 
sago starch factory wastewater82, textile wastewater83 and 
landfill leachate.84 In another study, marine microalgae 
grown in POME were suggested to be useful as 
aquaculture feed due to their high contents of PUFA.101 
There has been much interest in screening the 
indigenous microalgal resources of Malaysia for fine 
chemicals such as PUFA and pigments since 1990’s. 
Microalgae were isolated from various habitats in 
Malaysia and screened for those valuable products.102 
The University of Malaya Algae Culture Collection 
(UMACC) was then established to serve as a repository 
for the microalgal cultures.103 The UMACC which 
holds more than 150 microalgal isolates, is the largest 
and only microalgae culture collection in Malaysia. 
Of the many interesting microalgae in the collection, 
Chlorella vulgaris UMACC 001 is a very well-studied 
strain.104 The alga has potential applications in 
wastewater treatment and removal of heavy metals, and 
it grows well on organic carbon and at high nitrogen 
levels. Although the strain was isolated from freshwater 
habitat, it grows well at a wide range of salinities. 
Microalgal lipids, especially PUFA and carotenoids 
are amongst the targeted products from the algal 
resources of Malaysia.105 For instance, the marine diatom 
Nitzschia inconspicua produces appreciable amounts of 
EPA and arachidonic acid.106 Factors such as nitrate 
and silicate levels, and carbon source were found to 
affect the growth and fatty acid profiles of this diatom. 
Cultures aerated with 5% CO2 were found to produce 
highest yields of biomass and EPA. The current interest 
in microalgal lipids is mainly focused on their potential 
use for biodiesel production. The priority areas include 
screening of microalgal strains for high lipid producers, 
and the use of genomic, proteomic and metabolomic 
approaches to understand and enhance lipid synthesis 
in microalgae. 
The chlorophyte Ankistrodesmus convolutus was 
found to produce appreciable amounts of carotenoids, 
especially lutein and may have potential application as 
poultry feed.107 The biomass attained by this microalga 
increased when grown on glucose, although the 
carotenoid content decreased. Further manipulation by 
varying the irradiance and light-dark cycle to enhance S 33
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biomass and pigment production by Ankistrodesmus 
convolutus was also conducted.108 The cultures of the 
microalga were scaled up using a 6.5 L airlift fermenter 
to enhance biomass and pigment productivity.109 
A strain of marine cyanobacterium from the collection, 
Oscillatoria UMACC 216 was found to produce high 
amounts of phycoerythrin.110 Cells grown at 15 parts 
per thousand (ppt) of salt were found to produce 
highest amounts of phycoerythrin. In another study, 
the influence of irradiance and inoculum density on the 
pigmentation of Spirulina platensis was investigated.39 
The highest yield of phycocyanin was attained by 
cultures grown at low irradiance, developed from 
low-density inoculum. Under nitrogen-starvation, 
three strains of Spirulina platensis were also shown to 
produce high amounts of poly(3-hydroxybutyrate), 
which has potential application as bioplastic.111 
Several microalgae from the UMACC, including 
Spirulina platensis,  Ankistrodesmus convolutus and 
Synechococcus elongatus were screened for their 
antiproliferative activities against nasopharyngeal 
carcinoma (NPC) cells using bioassay-guided 
fractionation approach.112 It was found that 
Fraction 7’ obtained from column chromatography 
separation of the methanol extract from Synechococcus 
elongatus showed antiproliferative activity against 
NPC cells. It was suggested that the mechanism 
of action of the fraction was through induction 
of apoptosis and the active compound could be a 
derivative product of chlorophyll a. In another study, 
the inhibitory activities of extracts from the microalgae 
Ankistrodesmus convolutus, Synechococcus elongatus and 
Spirulina platensis against the release of Epstein-Barr 
virus (EBV) from lymphoblastoid cells were 
investigated.113 The HPLC sub-fraction SEF1’ from 
the methanol extract of Synechococcus elongatus was 
found to be most active in reducing the cell-free EBV 
DNA from lymphoblastoid cells. It was postulated that 
the active principles could be pigment components. 
Several microalgae, especially Spirulina platensis were 
also shown to have high antioxidant activity based on 
chemical assay.114 The aqueous extract from food-grade 
Spirulina platensis was also shown to have protective 
effect against apoptotic cell death due to free radicals.13 
Another interesting study on Malaysian microalgae 
was their potential application as larvicidal agents against 
Aedes aegyptii. A survey was conducted to investigate the 
correlation between the occurrence of microalgae and 
mosquito larvae in various mosquito breeding habitats 
in Malaysia.115 A total of 196 microalga were identified 
and some common microalgae found in the mosquito 
breeding sites include Chlorella sp. and Scenedesmus sp. 
The microalgae isolated were used to feed the larvae of 
Aedes aegypti.116,117 Of the chlorophytes tested, it was 
found that the percentage mortality of larvae fed with 
Chlorella vulgaris was the highest. There was also delayed 
pupation and body size reduction of the mosquitoes fed 
with  Chlorella vulgaris. Interestingly, larvae fed with 
another alga, Ankistrodesmus convolutus were larger than 
those fed with normal insectory feed. 
The applications of the microalgae from the UMACC 
for environmental biotechnology were further expanded 
with the addition of new isolates of from the Arctic and 
Antarctic. This new collection was established following 
the venture of Malaysian researchers into polar research 
since the year 2000.3,4 Diversity of polar microalgae at 
Ny Alesund in the Arctic3 and Casey Station in the 
Antarctic4 was documented following the expeditions to 
those sites. The cultures of polar microalgae established 
are very useful for the studies on stress response of such 
microalgae to global warming and increased ultraviolet 
radiation (UVR), in comparison with tropical and 
temperate species. The effects of climate change on 
microalgae, especially on how they respond and adapt to 
global warming and increased UVR has received much 
attention in recent years.118,119 For instance, the response 
of microalgae of similar taxa from the Antarctic, 
tropical and temperate regimes to UVR was compared 
based on their growth and biochemical composition.120 
Fatty acid profile was found to be a useful biomarker 
to assess the response of some Antarctic microalgae 
to UVR stress. The influence of temperature stress on 
the growth, biochemical composition and fatty acid S 34
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profiles of six Antarctic microalgae was reported by 
Teoh et al. (2004).121 The Antarctic Chlorella was found 
to be able to grow at temperatures much higher than 
the ambient, even up to 30°C. The differential gene 
expression of the Antarctic Chlorella in response to 
temperature was conducted.122 The gene that encodes 
Photosystem II P680 chlorophyll a apoprotein CP47 
(PSII-CP47) increased when the alga was exposed to 
cold temperature stress at 4°C. 
Conclusion
There is indeed a wide range of applications of 
microalgae in biotechnology. There is great potential to 
further exploit the rich microalgal resources of Malaysia 
for various biotechnological applications. In terms of 
applications in medical biotechnology, microalgae are 
potential sources of high-value products, including 
nutraceuticals, and bioactive molecules that may lead 
to the discovery of new drugs. The use of microalgae 
as a biological tool for monitoring and assessment of 
environmental toxicants is another application that 
has attracted much interest. Microalgal biotechnology 
should continue to be regarded as a priority area of 
research in Malaysia.
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